Smith Edward B III 4
4 · NightHawk Biosciences, Inc. · Filed Dec 9, 2022
Insider Transaction Report
Form 4
Smith Edward B III
Director
Transactions
- Award
Stock Option (right to buy)
2022-12-07+101,960→ 101,960 totalExercise: $1.02From: 2022-12-07Exp: 2032-12-07→ Common Stock (101,960 underlying)
Footnotes (1)
- [F1]These stock options vest monthly on a pro rata basis over a twelve-month period commencing on the date of grant.